Pursuant to CVM Instruction 358 of January 3, 2002, as amended (“CVM Instruction 358”), CVM Instruction 476 of January 16, 2009, as amended (“CVM Instruction 476”) and CVM Instruction 566 of July 31, 2015 (“CVM Instruction 566”), CCR S.A. (“CCR” or “Company”) (BM&FBovespa: CCRO3; Bloomberg: CCRO3 BZ; Reuters: CCRO3.SA) announces to its shareholders and the market in general that the Company’s Board of Directors, at a meeting held on April 7, 2020, approved its third (3rd) issue of commercial notes, in a single series, comprised of ten (10) commercial promissory notes for public distribution with restricted placement efforts, pursuant to CVM Instruction 476 and CVM Instruction 566, in the amount of four hundred million reais (R$400,000,000.00) (“Commercial Notes” and “Issue”, respectively), maturing in up to three hundred and sixty-five (365) days from the issue date. The Issue will be object of a public offering with restricted placement efforts and firm guarantee for all the Commercial Notes, in accordance with CVM Instruction 476 and other applicable legal and regulatory provisions and according to the terms and conditions established in the respective issue deeds of the Commercial Notes. Pursuant to CVM Instruction 566, the payment of remuneration interest will take place jointly with the payment of the principal amount on the maturity date of the Commercial notes.
The net proceeds from the Issue will be used to reinforce the Company’s cash balance.
São Paulo, April 7, 2020.
Investor Relations Officer